GO
Loading...

What's On: Novartis, Monsanto, Washington Post

Here's what's up on Wednesday's Squawk on the Street:

--The CEO of Novartis joins us. This company has a lot going on including a ground-breaking new drug designed to fight Multiple Sclerosis.

--We're also getting quarterly results from Monsanto, we'll have the numbers and instant stock reaction.

--Then the $300 a share club is talking about Washington Post's stock.

--Plus meet some college students that are beating the S&P handily over the last few years — they'll reveal the secrets to their success.

--Then, what's your tipping point? More high profile CNBC guests and commentators are saying they'd give up entitlements like Social Security and Medicare to save the country from a financial crisis. Would you?

--And meet the authors of a new book called "XXL: Obesity and the Limits of Shame." They're proposing government sponsored vouchers to help people fight fat. Vouchers would go to pay for diet programs, healthier food and more. Would you support it? Share your opinion, and watch the big show at 9 a.m. ET on the dot — profit from it.

Contact Squawk on the Street

  • Carl Quintanilla is an Emmy-winning reporter and co-anchor of CNBC's "Squawk on the Street," broadcast live from the NYSE.

  • Simon Hobbs co-anchors the 10 a.m. hour of CNBC's "Squawk on the Street" live from the New York Stock Exchange.

  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

  • “Squawk on the Street” Co-Anchor

  • Rick Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.